Things
Spoke 4 of the d3 4 Health project, called “Biological and bioengineered in vitro models for care through Digital Twin approaches” hereinafter “Spoke”, is aimed at achieving the following general objectives: 1) development, evaluation and exploitation of in vitro models for personalized medicine; 2) evaluation of new approaches for prognosis and disease monitoring of patient models to obtain personalized analyzes and data; 3) selection of the most appropriate therapy by testing drugs on patient-derived models; 4) extraction of new data/information from in vitro models to improve digital models.
Who is it aimed at?
The entities eligible to submit project proposals - Proponents - in response to this notice may be: a) Micro, Small and Medium Enterprises (MSMEs), external to the D3 4 Health Initiative, having the dimensional parameters set out in Annex I of the REG (EC) n. 800/2008 of the Commission of 6 August 2008 (General Block Exemption Regulation) in OJEU L 214 of 9.8.2008;b) Large Enterprises (GI), external to the D3 4 Health Initiative.
What does it predict
The total financial allocation of this notice is equal to €1,000,000.00 totally allocated to the regions of Southern Italy (Abruzzo, Basilicata, Calabria Campania, Molise, Puglia, Sardinia and Sicily).
